BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11432708)

  • 1. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
    Niklinski J; Niklinska W; Chyczewski L; Becker HD; Pluygers E
    Eur J Cancer Prev; 2001 Jun; 10(3):213-26. PubMed ID: 11432708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ; Wang Y; Yang PM
    Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.
    Cecener G; Tunca B; Egeli U; Karadag M; Vatan O; Uzaslan E; Tolunay S
    Tumori; 2008; 94(6):845-8. PubMed ID: 19267103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and antioncogenes in lung tumorigenesis.
    Giaccone G
    Chest; 1996 May; 109(5 Suppl):130S-134S. PubMed ID: 8635391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer epigenetics and genetics.
    Risch A; Plass C
    Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes in human lung cancer.
    Kratzke RA; Shimizu E; Kaye FJ
    Cancer Treat Res; 1992; 63():61-85. PubMed ID: 1363367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential biomarkers for the early detection of lung cancer.
    Gruidl ME; Shaw Wright GL
    J Thorac Imaging; 2000 Jan; 15(1):13-20. PubMed ID: 10634657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic changes found in human lung cancer and its precursor lesions.
    Gazdar AF; Bader S; Hung J; Kishimoto Y; Sekido Y; Sugio K; Virmani A; Fleming J; Carbone DP; Minna JD
    Cold Spring Harb Symp Quant Biol; 1994; 59():565-72. PubMed ID: 7587113
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology of lung cancer.
    Kalemkerian GP
    Curr Opin Oncol; 1994 Mar; 6(2):147-55. PubMed ID: 8011691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of lung oncogenesis].
    Brambilla E; Gazzeri S; Gouyer V; Brambilla C
    Rev Prat; 1993 Apr; 43(7):807-14. PubMed ID: 8346398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection and prevention of lung cancer.
    Wright GS; Gruidl ME
    Curr Opin Oncol; 2000 Mar; 12(2):143-8. PubMed ID: 10750726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogenes and anti-oncogenes in lung cancer].
    Demoly P; Pujol JL; Godard P; Michel FB
    Presse Med; 1994 Feb; 23(6):291-7. PubMed ID: 8208681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
    Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
    Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
    Geradts J; Fong KM; Zimmerman PV; Minna JD
    Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.
    Ooi AT; Gower AC; Zhang KX; Vick JL; Hong L; Nagao B; Wallace WD; Elashoff DA; Walser TC; Dubinett SM; Pellegrini M; Lenburg ME; Spira A; Gomperts BN
    Cancer Prev Res (Phila); 2014 May; 7(5):487-95. PubMed ID: 24618292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in non-small cell lung cancer prevention.
    Hilbe W; Dirnhofer S; Greil R; Wöll E
    Eur J Cancer Prev; 2004 Oct; 13(5):425-36. PubMed ID: 15452456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.